Meet our new member: AgileBiotics
Friday 7 July 2017
- Life Cooperative
AgileBiotics B.V. is a pharmaceutical company focusing on the discovery and development of novel antibiotcs for the treatment of multi-drug resistant infections.
AGILeBiotics is committed to contribute to the fight against bacterial resistance by bringing new therapeutic solutions to patients infected by multidrug resistant bacteria. Our vision is to accelerate the development of novel antibiotics by employing our technology OxaSelect on existing drugs, which are based on natural products, and give them a second life cycle on the antibiotic market.
AGILeBiotics is a spin-off company of the University of Groningen located in Groningen in the North of the Netherlands. The company is located in the InnoLab Chemie that offers state of the art laboratory facilities for start-up companies. All technologies AGILeBiotics is employing were co-invented and established at the University by the CEO of AGILeBiotics Dr. Andreas A. Bastian. Supported by the University of Groningen and the University Medical Center Groningen (UMCG), AGILeBiotics is developing its own drug pipeline of novel antibiotics to treat multidrug resistant infections.
Focus areasLife Cooperative
Tuesday 15 January 2019
InnoCore Pharmaceuticals will develop contraceptive micron..
Tuesday 4 December 2018
Welcome to new start up EV Biotech
Monday 5 November 2018
Worldwide market at LIFE Cooperatives feet
Thursday 13 September 2018
Polyganics strengthens global distribution network
Monday 3 September 2018
Lode Holding: initiator, participant and part of the Campu..
Tuesday 28 August 2018
A goldmine in Groningen: business in biobanking
Thursday 23 August 2018
Lode Holding & MercachemSyncom at the start of Campus ..
Tuesday 7 August 2018
AGILeBiotics further develops novel antibiotics
Monday 30 July 2018
Worldwide cooperation agreement InnoCore Pharmaceuticals a..
Thursday 5 July 2018
Covenant Personalized & Customized Health also signed..